Avantra Family Wealth’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$240K Sell
479
-183
-28% -$87.8K 0.15% 158
2026
Q1
$325K Buy
662
+183
+38% +$99.3K 0.24% 120
2025
Q4
$278K Hold
479
0.2% 129
2025
Q3
$232K Buy
+479
New +$223K 0.17% 149
2025
Q2
Sell
-479
Closed -$238K 162
2025
Q1
$238K Sell
479
-154
-24% -$83.4K 0.23% 135
2024
Q4
$329K Buy
+633
New +$348K 0.31% 113

Other funds holding TMO

Avantra Family Wealth's TMO Position: Q2 2026 in Review

Avantra Family Wealth reduced its Thermo Fisher Scientific (TMO) stake by 28% in Q2 2026, selling an estimated $87.8K and leaving 479 shares worth $240K. The position accounts for 0.15% of the portfolio, ranked #158.

Avantra Family Wealth first reported a position in TMO in Q4 2024 and has held it in 6 quarters since. The position peaked at $329K in Q4 2024. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Avantra Family Wealth held 479 shares of Thermo Fisher Scientific worth $240K as of Q2 2026.
  • Avantra Family Wealth sold 183 Thermo Fisher Scientific shares in Q2 2026, an estimated $87.8K.
  • Thermo Fisher Scientific made up 0.15% of Avantra Family Wealth's portfolio in Q2 2026, its #158 holding.
  • Avantra Family Wealth first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 6 quarters since.
  • Avantra Family Wealth's Thermo Fisher Scientific position peaked at $329K in Q4 2024.
  • 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Avantra Family Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.